Few substances in the psychedelic world are surrounded by as much mythology, misinformation, and outright confusion as toad medicine. Search the term and you will find ceremony videos, breathless testimonials, warnings from conservationists, and a surprising number of people who have no idea what they are actually looking at.
So let us be precise, because precision matters when the subject is a powerful psychoactive compound.
Toad medicine — commonly called Bufo medicine, or simply "Bufo" — is the colloquial name for the secretion of the Sonoran Desert toad, and for the psychedelic compound that secretion contains: 5-MeO-DMT. That is the whole answer in a sentence. Everything else is detail, and the detail is where people get into trouble.
If you want the full primer, our team has written a dedicated explainer on what toad medicine actually is and how Bufo works. This article is the companion piece: it addresses the questions people ask before they get that far, including a few strange ones.
First, a Disambiguation: "Bufo" Means Two Very Different Things
One of the most common search queries around this topic is some variation of "what is bufo in beef" — and it is worth addressing directly, because it reveals exactly how muddled the terminology has become.
Bufo is a taxonomic genus name. It is the historical scientific classification for true toads — hundreds of species of them, found across most of the world. When people encounter the word "Bufo" attached to agriculture, livestock, pest control, or veterinary contexts, they are encountering the biological genus, not the psychedelic practice. Toads are a well-documented hazard to dogs and livestock in some regions precisely because many species secrete defensive toxins. That is a veterinary and ecological topic with no relationship whatsoever to psychedelic therapy.
Toad medicine, by contrast, refers to one specific species and one specific compound:
- The species: Incilius alvarius, the Sonoran Desert toad, also called the Colorado River toad. It was formerly classified as Bufo alvarius — which is exactly where the nickname "Bufo" comes from and why the outdated name persists in psychedelic circles.
- The compound: 5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine), a tryptamine psychedelic present in the toad's parotoid gland secretion alongside bufotenin and other alkaloids.
So: the toad is a Bufo in the old naming system. The medicine is 5-MeO-DMT. And none of this has any connection to the food supply. If your search brought you here from a question about livestock or food safety, that is a genuinely different subject — and one worth asking a veterinarian about rather than a psychedelic clinic.
With that cleared up, let us talk about the actual medicine.
What the Experience Is Actually Like
5-MeO-DMT is pharmacologically distinct from nearly every other psychedelic people are familiar with, and the difference is not subtle.
Onset is nearly immediate. When vaporized and inhaled, effects typically begin within seconds — not the 30 to 60 minutes of psilocybin or the multi-hour build of ayahuasca. There is essentially no runway.
Duration is short. The core experience generally resolves within roughly 15 to 30 minutes, with a gentler tail afterward. Compare that to the 12-to-36-hour arc of an ibogaine session and you are looking at a fundamentally different kind of encounter.
The character is different, too. Where psilocybin and LSD tend to produce rich visual and narrative content, 5-MeO-DMT is far more often described in terms of dissolution — the collapse of the ordinary sense of being a separate self. People frequently report an absence of imagery rather than an abundance of it. Many describe it as the most profound experience of their lives. A meaningful number also describe it as the most frightening.
That last point deserves emphasis. The brevity of the experience is often mistaken for gentleness. It is not gentle. A short experience is not the same as an easy one, and the compressed onset gives a person almost no opportunity to orient themselves. This is precisely why set, setting, screening, and trained supervision matter so much — a subject we cover in more depth across our 5-MeO-DMT and Bufo alvarius therapy program.
What the Research Actually Shows — and What It Does Not
This is where responsible discussion of toad medicine tends to break down, so let us be careful.
The honest summary: 5-MeO-DMT research is early. The published evidence base consists largely of survey studies, observational reports, retrospective self-report data, and a small number of early-phase clinical trials — several of which use synthetic 5-MeO-DMT formulations under investigation for treatment-resistant depression. Findings from this body of work have been encouraging enough to sustain serious scientific interest, particularly around rapid and durable shifts in depression and anxiety symptoms.
But encouraging is not the same as established. Here is what has not happened:
- 5-MeO-DMT is not an FDA-approved treatment for any condition.
- There is no large-scale, long-term, placebo-controlled evidence base comparable to what exists for conventional psychiatric treatments.
- Survey and observational studies are vulnerable to selection bias — people who had transformative experiences are more likely to respond to surveys about them than people who did not.
Anyone who tells you that toad medicine is a proven cure for anything is either misinformed or selling something. The appropriate posture is genuine interest paired with genuine humility, which is the same posture we take toward the broader field in our psychedelic medicine research reviews.
The Safety Conversation Nobody Has Often Enough
If you take one practical thing from this article, make it this section.
Serotonergic drug interactions are the central risk
5-MeO-DMT is a potent serotonergic agent. Combining it with MAO inhibitors, and potentially with SSRIs, SNRIs, and certain other serotonergic medications, carries a risk of serotonin syndrome — a medical emergency that can be fatal. This is not a theoretical concern; it is the mechanism behind a meaningful share of the serious adverse events associated with the substance.
Any legitimate program will conduct a full medication review before a session and will require appropriate tapering timelines where indicated. If a provider does not ask what medications you take, that is a disqualifying red flag.
Cardiovascular and psychiatric screening are non-negotiable
Blood pressure and heart rate changes, pre-existing cardiac conditions, and personal or family history of psychotic-spectrum disorders all need to be evaluated by a clinician before anyone considers a session.
Dosing from raw toad secretion is inherently imprecise
Secretion collected from wild animals varies in alkaloid concentration by individual toad, by season, by geography, and by collection method. There is no standardization. This is a real and under-discussed hazard.
Unsupervised use is where harm concentrates
The physical incapacitation during a session is total. A person needs someone trained present — for airway management, for physical safety, and for the psychological aftermath.
Our frequently asked questions about psychedelic therapy address many of the screening specifics people ask about before reaching out.
The Ethical Problem at the Heart of Toad Medicine
Here is the part of the conversation that the ceremony marketing tends to skip.
The Sonoran Desert toad is a wild animal, and the global popularity of Bufo has placed real pressure on its populations. Toads are collected, handled, and "milked" — often repeatedly, often by people with no training in animal welfare, sometimes trafficked across borders. Conservationists and herpetologists have raised sustained concerns about the impact of this trade on a species with a limited range.
There is a straightforward solution, and it is worth stating plainly: synthetic 5-MeO-DMT is chemically identical to the compound found in the secretion. The molecule does not know or care where it came from. Using a synthesized, purity-verified compound eliminates the animal welfare problem entirely, removes the contaminants and unknown alkaloids present in raw secretion, and — critically — allows for accurate, consistent dosing.
Choosing synthetic is simultaneously the more ethical option and the safer one. There is no meaningful argument for wild-harvested secretion other than tradition and marketing, and neither is a good reason to stress a wild species or to dose a human being with an unquantified substance.
Where Toad Medicine Fits in a Broader Treatment Picture
5-MeO-DMT is not a standalone answer, and it is not appropriate for everyone.
For people whose primary struggle is physical dependence — opioids, alcohol, stimulants, kratom — a short-acting psychedelic does not address withdrawal physiology. That is a different clinical problem requiring a different tool, which is why our physician-supervised ibogaine treatment program exists as a separate pathway with its own screening protocol and medical monitoring requirements.
Some people benefit from a sequenced approach, and we have written about the combined ibogaine and 5-MeO-DMT protocol for those curious about how the two are used together in a structured setting. Others are better served by a slower, more gradual modality such as a psilocybin therapy retreat, where the extended duration allows for guided processing during the experience itself.
And for everyone, regardless of modality: integration is where the value is realized. A profound 20 minutes changes very little on its own. What changes a life is the structured work that follows — the weeks of translating an experience into altered behavior, repaired relationships, and sustained clinical support. Programs that offer the session without the follow-through are selling an event, not a treatment.
Legal Status: Know Before You Go
In the United States, 5-MeO-DMT is a Schedule I controlled substance under federal law. Possession and distribution carry serious legal consequences. The toad itself is additionally protected under state wildlife regulations in parts of its range.
Legal frameworks differ substantially in other jurisdictions, and this is a primary reason supervised programs operate outside the United States. If you are evaluating any provider, verify the legal standing of the program in its jurisdiction as carefully as you verify its medical credentials.
Questions Worth Asking Any Provider
Before committing to any toad medicine program, ask:
- Is the compound synthetic 5-MeO-DMT or wild-harvested secretion? What is the purity verification process?
- What is the exact dose in milligrams, and how is it measured?
- Who conducts medical screening, and what are their qualifications?
- What is your protocol for medication interactions and tapering?
- What emergency medical capability is on site — and how far is the nearest hospital?
- What does integration support consist of, and for how long after the session?
- What is the legal status of this program where it operates?
A program that answers all seven clearly and without defensiveness is worth continued conversation. Anything less is not.
If you would like to talk through whether any of this is appropriate for your situation, you can schedule a consultation with our medical team, review our treatment program pricing and packages, or read more about the structure of our retreat programs in Cozumel.
The Bottom Line
Toad medicine is real, it is powerful, and it is genuinely interesting to researchers — but it is early-stage, it is not approved, it carries meaningful medical risk, and the traditional wild-harvested sourcing raises ethical problems that a synthetic alternative solves completely.
The people who do best with this compound are the ones who approach it with clear eyes: properly screened, properly dosed, properly supervised, and properly supported afterward. The people who get hurt are almost always the ones who treated a 20-minute experience as if brevity implied safety.
Take it seriously, and it may have something to offer. Take it casually, and it will not be gentle with you.
Medical Disclaimer
This article is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. 5-MeO-DMT is not approved by the FDA for the treatment of any condition, and it is a Schedule I controlled substance under United States federal law. Nothing here should be interpreted as encouragement to obtain or use any controlled substance. Psychedelic compounds carry real medical risks, including potentially fatal interactions with antidepressants and other serotonergic medications. Never discontinue or adjust a prescribed medication without direct supervision from your prescribing physician. Always consult a qualified healthcare provider before making any decision about your treatment.
If you are in crisis: In the United States, call or text 988 to reach the Suicide & Crisis Lifeline, available 24 hours a day, seven days a week. If you are experiencing a medical emergency, call 911 or go to your nearest emergency room immediately.
Begin Your Journey
MindScape Retreat offers medically supervised ibogaine treatment in Cozumel, Mexico. Speak with our clinical team to learn if you are a candidate.


